ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 1 filers reported holding ORCHARD THERAPEUTICS PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $5,233,000 | -1.9% | 1,192,003 | +62.3% | 0.02% | 0.0% |
| Q1 2021 | $5,332,000 | +271.3% | 734,431 | +120.9% | 0.02% | +360.0% |
| Q4 2020 | $1,436,000 | +1.8% | 332,502 | -3.1% | 0.01% | -16.7% |
| Q3 2020 | $1,411,000 | -42.0% | 343,202 | -15.4% | 0.01% | -45.5% |
| Q2 2020 | $2,434,000 | -20.3% | 405,702 | 0.0% | 0.01% | -42.1% |
| Q1 2020 | $3,055,000 | -45.2% | 405,702 | 0.0% | 0.02% | -36.7% |
| Q4 2019 | $5,578,000 | +15.7% | 405,702 | 0.0% | 0.03% | -9.1% |
| Q3 2019 | $4,820,000 | -15.1% | 405,702 | 0.0% | 0.03% | -15.4% |
| Q2 2019 | $5,676,000 | +154.0% | 405,702 | +224.6% | 0.04% | +178.6% |
| Q1 2019 | $2,235,000 | +13.7% | 125,000 | 0.0% | 0.01% | -12.5% |
| Q4 2018 | $1,966,000 | – | 125,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 2,931,185 | $12,047,000 | 4.29% |
| RA Capital Management | 12,315,213 | $50,616,000 | 0.93% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,949,416 | $28,562,000 | 0.70% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 620,233 | $2,549,000 | 0.35% |
| Casdin Capital, LLC | 1,870,000 | $7,686,000 | 0.34% |
| Vivo Capital, LLC | 1,325,736 | $5,449,000 | 0.32% |
| Bleichroeder LP | 250,000 | $1,028,000 | 0.18% |
| Virtus ETF Advisers LLC | 40,292 | $166,000 | 0.09% |
| Forefront Analytics, LLC | 30,369 | $123,000 | 0.06% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 411,977 | $1,693,000 | 0.04% |